Odonate Therapeutics, Inc. Stock-Based Compensation
Odonate Therapeutics, Inc. reported Stock-Based Compensation of $4.18 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2021-11-10
- Odonate Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2021-09-30 was $743.00K, a 68.26% decline year-over-year.
- Odonate Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2021-06-30 was $1.34M, a 48.40% decline year-over-year.
- Odonate Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2021-03-31 was $2.10M, a 18.83% decline year-over-year.
- Odonate Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2020-12-31 was $2.31M, a 16.11% decline year-over-year.
- Odonate Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $9.83M, a 14.12% decline from fiscal 2019.
- Odonate Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2019 was $11.44M, a 70.27% increase from fiscal 2018.
- Odonate Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2018 was $6.72M, a 111.09% increase from fiscal 2017.
- Odonate Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2017 was $3.18M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2021-09-30 | $743.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.08M derived: sum of 2 quarters · filed 2021-11-10 | $4.18M 10-Q · filed 2021-11-10 | $6.49M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $3.44M 10-Q · filed 2021-07-27 | $5.74M derived: sum of 3 quarters · filed 2021-07-27 | $8.09M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | $2.10M 10-Q · filed 2021-05-14 | $4.41M derived: sum of 2 quarters · filed 2021-05-14 | $6.75M derived: sum of 3 quarters · filed 2021-11-10 | $9.34M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $4.65M derived: sum of 2 quarters · filed 2021-11-10 | $7.24M derived: sum of 3 quarters · filed 2021-11-10 | $9.83M 10-K · filed 2021-02-23 |
| 2020-09-30 | $2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $4.94M derived: sum of 2 quarters · filed 2021-11-10 | $7.52M 10-Q · filed 2021-11-10 | $10.27M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $5.18M 10-Q · filed 2021-07-27 | $7.93M derived: sum of 3 quarters · filed 2021-07-27 | $10.71M derived: sum of 4 quarters · filed 2021-07-27 |
| 2020-03-31 | $2.59M 10-Q · filed 2021-05-14 | $5.33M derived: sum of 2 quarters · filed 2021-05-14 | $8.12M derived: sum of 3 quarters · filed 2021-05-14 | $11.11M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $5.53M derived: sum of 2 quarters · filed 2021-02-23 | $8.52M derived: sum of 3 quarters · filed 2021-02-23 | $11.44M 10-K · filed 2021-02-23 |
| 2019-09-30 | $2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $5.77M derived: sum of 2 quarters · filed 2020-10-28 | $8.70M 10-Q · filed 2020-10-28 | $10.64M derived: sum of 4 quarters · filed 2020-10-28 |
| 2019-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $5.92M 10-Q · filed 2020-07-30 | $7.86M derived: sum of 3 quarters · filed 2020-07-30 | $10.04M derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | $2.92M 10-Q · filed 2020-04-28 | $4.87M derived: sum of 2 quarters · filed 2020-04-28 | $7.05M derived: sum of 3 quarters · filed 2020-04-28 | $8.63M derived: sum of 4 quarters · filed 2020-04-28 |
| 2018-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $4.12M derived: sum of 2 quarters · filed 2020-02-20 | $5.71M derived: sum of 3 quarters · filed 2020-02-20 | $6.72M 10-K · filed 2020-02-20 |
| 2018-09-30 | $2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $3.76M derived: sum of 2 quarters · filed 2019-11-06 | $4.78M 10-Q · filed 2019-11-06 | $5.76M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $2.60M 10-Q · filed 2019-07-24 | $3.59M derived: sum of 3 quarters · filed 2019-07-24 | $5.47M derived: sum of 4 quarters · filed 2019-07-24 |
| 2018-03-31 | $1.01M 10-Q · filed 2019-04-25 | $2.00M derived: sum of 2 quarters · filed 2019-04-25 | $3.88M derived: sum of 3 quarters · filed 2019-04-25 | $4.19M derived: sum of 4 quarters · filed 2019-04-25 |
| 2017-12-31 | $986.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $2.87M derived: sum of 2 quarters · filed 2019-02-22 | $3.17M derived: sum of 3 quarters · filed 2019-02-22 | $3.18M 10-K · filed 2019-02-22 |
| 2017-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $2.19M derived: sum of 2 quarters · filed 2018-10-23 | $2.20M 10-Q · filed 2018-10-23 | |
| 2017-06-30 | $301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | $310.00K 10-Q · filed 2018-07-30 | ||
| 2017-03-31 | $9.00K 10-Q · filed 2018-05-03 |